Abstract
Machine learning approaches are increasingly being applied to neuroimaging data from patients with psychiatric disorders to extract brain-based features for diagnosis and prognosis. The goal of this review is to discuss recent practices for evaluating machine learning applications to obsessive-compulsive and related disorders and to advance a novel strategy of building machine learning models based on a set of core brain regions for better performance, interpretability, and generalizability. Specifically, we argue that a core set of co-altered brain regions (namely ‘core regions’) comprising areas central to the underlying psychopathology enables the efficient construction of a predictive model to identify distinct symptom dimensions/clusters in individual patients. Hypothesis-driven and data-driven approaches are further introduced showing how core regions are identified from the entire brain. We demonstrate a broadly applicable roadmap for leveraging this core set-based strategy to accelerate the pursuit of neuroimaging-based markers for diagnosis and prognosis in a variety of psychiatric disorders.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Psychiatric heterogeneity and comorbidity are ubiquitous in the categorical diagnosis of mental disorders, and this remains a bottleneck for precision diagnosis and personalized therapy [1,2,3,4]. Obsessive-compulsive disorder (OCD) is a highly complex and disabling psychiatric disorder characterized by obsessions and/or compulsions [5, 6], with a lifetime prevalence of ~ 1% to 2% worldwide [7]. Obsessions are repetitive thoughts, images, or urges that are intrusive and cause distress or anxiety, such as fear of contamination. Compulsions are repetitive and stereotyped behaviors that patients feel driven to perform to reduce the anxiety associated with obsessions, such as washing and cleaning. The current gold standard for a clinical diagnosis of OCD relies on the symptom-based criteria of the Diagnostic and Statistical Manual of Mental Disorders [8], and the symptom severity of patients with OCD is typically quantified by behavioral assessment instruments such as the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) [9]. The need to unbolt the shackles of the multifaceted symptom dimensions that characterize OCD, as well as phenotypes that co-occur with other disorders, has led researchers to search for objective and tangible biomarkers for diagnosis and treatment prognosis in the individual [10].
Brain imaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) have demonstrated their capacity for non-invasive investigation of brain structure and function in patients with OCD, leading to unprecedented advancement in the characterization of its etiology [11]. Specifically, structural and functional alterations in patients with OCD have been found in the orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), dorsolateral prefrontal cortex (PFC), inferior frontal gyrus (IFG), insula, amygdala, striatum, and thalamus; these were central to the development of the traditional cortico-striato-thalamo-cortical hypothesis [5]. Different degrees and patterns of alterations in these neurocircuits in individuals with OCD are thought to lead to phenotypic heterogeneity and variable responses to pharmacotherapy and neurosurgical interventions [12,13,14,15,16]. To resolve the heterogeneity in OCD, psychiatrists have attempted to group patients with OCD based on clinical manifestations, and four subtypes have been consistently identified: contamination/washing, aggression/checking, symmetry/ordering, and hoarding [17]. Subsequent neuroimaging studies have confirmed the distinct neural mechanisms underlying these subtypes [18, 19]. In subjects with obsessive-compulsive traits, data-driven clustering of symptoms has revealed two subgroups with distinct symptom patterns and structural abnormalities [20]. Focused on the heterogeneity in brain imaging, recent studies have also identified subtypes of OCD with distinct neuroimaging abnormalities [21]. However, our understanding of OCD psychopathology stems predominantly from studies using case-control designs to focus on group differences between patients and healthy controls, which have proven challenging to translate into clinical utility. As such, characterizing individual structural and functional variations in the psychiatric brain has become an important prerequisite to the pursuit of translationally valuable imaging biomarkers.
Machine learning algorithms are increasingly being combined with neuroimaging techniques to make inferences about the health status of subjects at the individual level, thereby enabling the automatic and objective diagnosis of psychiatric disorders [22] (Fig. 1). This technique has been used in numerous recent investigations to distinguish patients with OCD from healthy controls (HCs) [23]. Here, we will briefly introduce the pipeline for these machine-learning techniques; further technical details can be found in several excellent recent reviews [22].
Although specific procedures might vary at different stages across studies, the typical analysis pipeline includes the following steps. The first step is to transform neuroimaging data into features. This involves deciding which features to use and extracting feature values from the data. The term ‘feature’ refers to any derived variable containing valuable information about the class labels that can be extracted from the data. Different types of features in neuroimaging data can be used for classification purposes. For example, features can be extracted at the voxel level, or based on pre-defined areas (regions of interest) from a structural or functional brain atlas. Alternatively, multiple voxels across a brain network can be combined using dimension reduction techniques or joint estimation of multimodal features. Once features have been extracted from a training dataset, the number of features is most often reduced either using a data-driven method or based on prior knowledge [24]. Next, the selected features are fed into the machine learning algorithms to learn from the labeled data. A classifier is a function that takes features as input and generates a class label prediction. Popular machine learning classifiers for mental disorders include the support vector machine (SVM), logistic regression (LR), and random forest approaches [25]. Constructed classifiers require validation to determine model performance and generalizability, for which k-fold cross-validation (CV) is widely-used. To mitigate overfitting and performance bias, it is critical to analyze training and testing datasets independently. In k-fold CV, the most parsimonious way is to evenly divide the complete dataset into k test sets: k − 1 sets combined for model training, and one left-out set for testing. The average performance gives an approximation of the quality of models generated with this training algorithm. When the sample size is small, a special form of k-fold CV known as leave-one-out cross-validation (LOOCV) is typically adopted, where k is the total number of subjects. Finally, classification performance can be evaluated with metrics such as accuracy, specificity, sensitivity, and the area under the curve (AUC) of the receiver operating characteristic (ROC) curve. These metrics evaluate different aspects of classifier performance. Accuracy reflects how many cases were correctly classified out of the total (patients and HCs). Meanwhile, sensitivity and specificity refer to the proportion of correctly identified patients and HCs, respectively. The ROC curve is commonly used to demonstrate the trade-off between sensitivity and specificity, with a larger AUC of the ROC corresponding to the better overall performance of the classifier.
Despite their widespread use, current machine-learning models face a number of notorious challenges that require further consideration. One such challenge is that the number of features in a neuroimaging dataset is typically several orders of magnitude larger than the number of subjects, namely, the curse of dimensionality. Effective feature engineering can therefore significantly reduce the computational load and improve efficiency and performance [26, 27], particularly by taking advantage of the neurocircuitry characteristics of brain diseases [28]. The consensus on what constitutes pathological circuits underlying psychiatric disorders like OCD is that widespread structural and functional alterations over the whole brain are implicated whereas not all brain regions are uniformly involved in the etiology of OCD [6, 29]. Screening key brain-based features to separate them from less relevant features is both crucial and beneficial. Here, we review studies relevant to the diagnostic classification of OCD to underscore the contribution of core pathological regions. We then propose a novel classification strategy based on features from a set of core brain regions, and evidence endorsing this concept is discussed. A wide range of methods that aid in screening these core regions out of the whole brain is discussed. Finally, we outline future directions to accelerate the pursuit of imaging biomarkers in the diagnosis and prognosis of OCD.
Diagnostic Biomarkers for OCD
In this review, we concentrate on MRI modalities as they have been most widely applied in the machine-learning literature related to OCD [30]. In July 2022, a systematic literature search was done using PubMed with the following inclusion criteria: (1) MRI data were acquired; (2) a machine learning algorithm was used to classify patients with OCD and HCs; (3) the article was published in a peer-reviewed journal; (4) the article was in English. This search resulted in 24 relevant studies which are reviewed here [31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54]. Data from three MRI modalities were analyzed in these studies: structural (6 articles), functional (16 articles), and diffusion (1 article) MRI. Only one study used both structural and diffusion imaging data [40], but the combination of any two modalities in one classifier was not explored. See Table 1 for a summary of these studies and the methods used.
Functional MRI
To date, only one study [48] has used a task-based functional MRI dataset to distinguish patients with OCD from HCs (OCD = 10, HC = 10). Affective pictures from three categories were presented during functional MRI scanning. A two-step pattern recognition analysis was conducted to classify subjects into two groups. They trained a linear support vector classifier to distinguish the picture categories based on the subject’s brain response, and a searchlight method was then applied to predict the diagnostic label of the subjects with information from the first step. The predictive power of features extracted from the OFC and the caudate nucleus even reached close to 100.0% accuracy, a finding that certainly requires future validation with multi-site and large-scale external data.
Since the pilot work of Biswal et al. [55], resting-state functional MRI has become a popular technique to investigate functional dysfunction in psychiatric disorders [56, 57]. Multiple measures derived from resting-state fMRI data have been used as candidate features trained for the diagnosis of OCD, such as the functional connectivity, the amplitude of low-frequency fluctuations (ALFF), the fractional amplitude of low-frequency fluctuations (fALFF), and regional homogeneity (ReHo). Gruner et al. [41] were the first to perform diagnostic classification for OCD based on 36 functional networks decomposed from resting-state functional data. The assembly of three networks combined with the LR algorithm achieved the highest performance at an accuracy of 80.1%, including the middle frontal/dorsal anterior cingulate network, the anterior/posterior cingulate network, and the visual network. Hu et al. [37] focused on ReHo maps to train SVM classifiers in tandem with LOOCV achieving 79.0% accuracy for patients with OCD (sensitivity 78.4%, specificity 79.6%). The key regions contributing to the SVM classifier were the right OFC, dorsal ACC, inferior parietal cortex, temporal regions, and cerebellum, among which the right OFC exhibited the highest discriminative power. Using features derived from the fALFF map, Yang et al. [33] applied SVM to discriminate 68 drug-naïve patients with OCD from 68 HCs. The overall accuracy was 72.0% with 68.0% sensitivity and 76.0% specificity. Brain regions contributing to the discrimination consisted of the left superior temporal gyrus, the right middle temporal gyrus, the left supramarginal gyrus, and the superior parietal lobule. Jia et al. [39] adopted the voxel-mirrored homotopic connectivity method to investigate interhemispheric coordination in OCD. Patients with OCD showed significantly decreased homotopic connectivity in the OFC, thalamus, middle occipital gyrus, precentral gyrus, and postcentral gyrus compared with HCs. Exploratory SVM was performed with homotopic connectivity indices based on these five brain regions and all possible pairwise combinations. And they found that a combination of the thalamus and postcentral gyrus achieved the highest accuracy of 94.9%. In drug-naïve patients with OCD, Bu et al. [53] tested a wide range of imaging features extracted from ALFF, fALFF, ReHo, and functional connectivity strength, and found that the SVM classifier yielded the highest accuracy of 95.4% with ALFF extracted from the PFC, ACC, precentral gyrus, and occipital lobes. Liu et al. [35, 51] conducted a series of studies to distinguish medication-free patients from HCs with effective connectivity and functional connectivity. The combined classifier outperformed the classifiers with any type of connectivity (80.5% accuracy). To reduce the number of features extracted from whole-brain functional connectivity, Takagi et al. [52] applied principal component analysis to reduce the number of features from nearly 10,000 down to the number of participants. An additional feature selection procedure, canonical correlation analysis, was applied to extract smaller sets of features related to diagnosis. The selected features were then entered into a sparse LR model, and the LOOCV achieved an accuracy of 73.0% in the training dataset. They further tested the classifier in an external dataset (OCD = 10, HC = 18), and the AUC of the classifier was 0.7.
In addition, new functional measures were developed to expand the application of functional data in diagnostic classification. Liu et al. [43] applied a sliding-window approach to extract the dynamic ALFF as features in 73 OCD and 73 HCs. The SVM classifier with 10-fold CV successfully distinguished patients (83.6% accuracy, 80.8% sensitivity, and 86.3% specificity) from HCs with the most discriminative regions located in the inferior parietal lobule, dorsolateral PFC, middle occipital gyrus, and cuneus. Luo et al. [38] used distance correlation to construct the functional connectivity matrices (OCD = 61, HC = 67), and the best discriminative features were selected by SVM recursive feature elimination with a 10-fold CV strategy. The features from distance correlation achieved an accuracy of 93.0% (89.7% specificity and 95.1% sensitivity), superior to features from either Pearson correlation or partial correlation. The most discriminative features from distance correlation were distributed in the right dorsolateral PFC, orbital part of left superior frontal gyrus and right middle frontal gyrus, right ACC, paracingulate gyri, left supplementary motor area, and right precuneus.
Recent developments along this line of research focus on new machine-learning models to boost classification performance [31, 34, 49]. In a small dataset (OCD = 15, HC = 13), Sen et al. [49] introduced an information-theoretic approach to extract features from resting-state data and found that the features derived from the differential sub-graph (edge) entropy achieved better performance (89.1% accuracy, 100.0% specificity, and 80.0% sensitivity) than other feature engineering methods. The most discriminative features were located in the frontal lobe, parietal lobe, ACC, posterior cingulate gyrus, thalamus, default mode network, nucleus accumbens (NAc), and amygdala. Using whole-brain functional connectivity matrices, Xing et al. [34] put forward a new Riemann Kernel principal component analysis for feature extraction. The proposed feature selection algorithm combined with an XGBoost classifier yielded the highest accuracy (91.8%). The decisive features were found in intra-cerebellar connectivity, connectivity between the cerebellum and basal ganglia, connectivity between the rectus and parahippocampal gyrus, as well as corticothalamic connectivity. Yang et al. [46] integrated deep learning with traditional machine learning in one framework to distinguish 62 OCD from 65 HCs. A novel spatial similarity-aware learning model was proposed to construct the functional connectivity matrix, and a fused deep polynomial network model was subsequently applied to learn informative features. The SVM classifier with these informative features yielded the best performance (87.6% accuracy, 95.2% sensitivity, and 83.6% specificity) among features extracted from other types of functional connectivity and other feature learning methods. The most effective features were connected with OFC, IFG, insula, middle cingulate cortex, putamen, thalamus, temporal cortices, and parahippocampal cortex. Kalmady et al. [32] predicted the diagnosis of OCD (OCD = 175, HC = 175) with an established framework called EMPaSchiz, which was proposed to extract both regional and connectivity-based features onto 14 different brain parcellation schemes in schizophrenia [58]. The EMPaSchiz algorithm with an LR classifier was able to predict OCD with 80.3% accuracy using the 5 times 5-fold CV, outperforming the neural network model. The most important features were distributed in several functional brain networks, such as the default mode, language, attention, visual, auditory, motor, and salience networks. Using a cross-species strategy, a recent study transferred the features extracted from transgenic monkeys to discriminate HCs from patients in several psychiatric disease cohorts, including autism spectrum disorder (ASD), OCD, and attention deficit hyperactivity disorder [31]. A set of core brain regions distributed in the frontal and temporal cortices was extracted from the monkey dataset and then used to construct a new classifier to classify human patients in multiple independent clinical cohorts. In the OCD cohort, the monkey-derived classifier achieved an average accuracy of 78.4%.
Structural MRI
As a clinically valuable tool, MRI measurement has been applied to non-invasively quantify the morphological structure of the gray and white matter in psychiatric patients. In 2007, Soriano-Mas et al. [47] applied voxel-wise t-tests to compare the regional gray matter volume of the whole brain in a cohort (OCD = 72, HC = 72) and defined the individual expression value as the scalar product of an individual volumetric map of gray matter by the t map of group differences between OCD and HC. Next, the Euclidean distances between individual expression values and each group’s mean expression value were used as candidate features to train a classifier for the diagnostic classification of OCD. The classifier yielded an accuracy of 93.1% in the training cohort with LOOCV, while the overall accuracy was only 76.6% in an independent cohort (OCD = 30, HC = 30). The most relevant features were found in the OFC/medial PFC, the posterior cingulate cortex/precuneus, cerebellum, posterior insula, ventral striatum, and thalamus. Trambaiolli et al. [44] aimed to distinguish 38 patients with OCD from 36 HCs using the volumetric data of 117 cortical and subcortical regions. All 117 features were submitted to 7 kinds of feature selection algorithms and trained with SVM classifiers in a LOOCV fashion. Interestingly, the t-test feature selection method yielded the best performance, with an average accuracy of 71.6%. The most discriminative and consistent features were found in the left caudate, bilateral putamen, bilateral IFG, left precentral gyrus, right fusiform gyrus, and right lateral OFC. Parrado-Hernández et al. [45] proposed a new feature selection method for classification with structural MRI data in OCD. To identify stable features, voxel-wise features were selected by training an ensemble of linear classifiers based on randomly selected GMV data. In their cohort (OCD = 86, HC = 86), these features achieved an accuracy of 73.8% with 74.1% sensitivity and 73.6% specificity. The stable features contributing to the classification were widely distributed in the brain, including the OFC, PFC, ACC, insula, temporal, and parietal cortices, as well as subcortical structures like the caudate, putamen, and thalamus.
In some studies, many types of structural measures have been used to gather more information. Based on the treatment response to pharmacotherapy, Yun et al. [50] divided the patients with OCD into responders (n = 25) and non-responders (n = 31). Cortical thickness and cortical surface area before treatment were estimated from structural MRI data and used to construct pair-wise structural covariance networks in individuals. A univariate t-test was applied in a leave-one-out manner to identify the significant differences in the structural covariance network as features. The SVM classifiers were trained to successfully differentiate HCs from responders or non-responders among patients with OCD (OCD responders versus HC: 95.6% accuracy, OCD non-responders versus HC: 90.7% accuracy). Hu et al. [36] used both gray matter and white matter volume data for OCD classification. Both SVM and Gaussian process classifiers were trained to examine the classification performance of different tissue types. The best classification performance (81.8% accuracy) was achieved by the SVM classifier with white matter volumetric data, and white matter regions with superior discriminative power were located in the middle frontal gyrus, inferior parietal gyrus, inferior temporal gyrus, precentral and postcentral gyri, and occipital cortices. With both structural and diffusion MRI datasets obtained from a cohort of 48 patients with OCD from 45 HCs, Zhou et al. [40] fed four types of features (gray matter volume, white matter volume, fractional anisotropy, and mean diffusivity) into the SVM classifiers. The classification performance of features extracted from diffusion MRI was better than that from structural MRI. The most discriminative regions for classification were located in the angular gyrus, ACC, paracentral lobule, inferior parietal gyrus, IFG, and cerebellum.
Notably, an international OCD working group within the Enhancing Neuro-Imaging Genetics Through Meta-Analysis (ENIGMA) was initiated to aggregate structural MRI data of OCD around the world [59, 60]. Using large-scale data from ENIGMA (OCD = 2304, HC = 2608), Bruin et al. [54] extracted cortical thickness, surface area, and subcortical volume as classification features and submitted them to multiple machine learning models, but achieved relatively poor performance after rigorous cross-validation procedures. When the inter-site cross-validation procedure was implemented, classification performance acutely dropped to chance level.
Diffusion MRI
A variety of metrics derived from diffusion MRI data have been used as classification features to discriminate OCD from HCs. For instance, Li et al. [42] applied fractional anisotropy to train the SVM classifier and identified patients with 84.0% accuracy (86.0% sensitivity, 82.0% specificity). The white matter regions contributing to classification were mainly located in the bilateral prefrontal and temporal white matter, inferior frontal-occipital fasciculus, superior frontoparietal fasciculus, splenium of the corpus callosum, and left middle cingulum bundle. In a cohort of 93 subjects (OCD = 48 and HC = 45), Zhou et al. [40] found that the classification performance of SVM with fractional anisotropy was better than that with mean diffusivity (80.7% versus 77.4%). The most discriminative fiber tracts included the uncinate fasciculus, corticospinal tract, inferior cerebellar peduncle, superior cerebellar peduncle, cingulum, pontine crossing tract, and cerebral peduncle.
Current Status
All reviewed papers reported successful classification of patients with OCD and HCs, with accuracies ranging from 50.0% to 100.0%. Although the performance of diagnostic classification in a small population is promising, it has been suggested that studies of this kind often suffer lower generalizability [22]. Moreover, due to the limited sample size, the majority of investigations implemented the LOOCV method to train classifiers, and very few studies validated their models with external data [47, 52, 54]. On the other hand, despite the largest sample size available in the ENIGMA-OCD consortium, the overall classification accuracy was far from the diagnostic criterion, which indicated the effects of confounding factors like personal medication status on classification performance. In addition to potential technical issues that could contribute to poor performance in cohorts with large sample sizes [22], we believe that suboptimal strategies of feature engineering in MRI-based brain connectomics remain a key obstacle to unleashing the power of machine learning models for psychiatric diagnosis.
Screening Core Regions in OCD
The Concept of Core Regions and Relevant Evidence in OCD
Here we propose a novel machine-learning framework based on a set of core regions for diagnostic classification. Only a subset of brain regions (not all regions) indispensable to the neuropathology of brain diseases like OCD is considered as core regions. We argue that feature engineering confined to a selective neural network consisting of a set of core regions, rather than the entire brain, would effectively improve efficacy and achieve superior performance, substantially reducing the dimensionality of candidate features by discarding regions irrelevant to the underlying psychopathology. Below we elaborate on the concept of core regions in the context of OCD etiology, which can conveniently be extended to other psychiatric disorders.
Early neuroimaging studies of individuals with OCD found both structural and functional abnormalities in the OFC, ACC, caudate, and thalamus [61,62,63,64,65,66,67]. Dysfunction in the OFC-caudate circuit is one of the most consistently reported findings in the field [6] and appears to be clinically meaningful, with dysmetabolism in the left OFC, bilateral PFC, and ACC associated with the severity of symptoms in individual patients [64]. Recent technological developments in the fields of neuroimaging and computational psychiatry have further elucidated the roles of the IFG, ACC, insula, parietal cortex, striatum, thalamus, and cerebellum in the pathophysiology of OCD [59, 60, 68]. Moreover, different neural circuits may underlie distinct domains of neurocognitive impairment in OCD [69]. The concept of core regions relies on leveraging such findings to formulate a machine-learning model that can investigate a specific symptom dimension or behavioral domain of OCD. For instance, dysfunction in ventral cognitive circuits (composed of the IFG, ventrolateral PFC, ventral caudate, and thalamus) are likely to drive maladaptive self-regulatory behaviors in patients with OCD [70]. Put together, a core set of regions including OFC, ACC, IFG, dorsolateral PFC, insula, amygdala, striatum, and thalamus has been heavily implicated in the pathophysiology of OCD (see Fig. 2A from meta-analysis).
In treatment-resistant OCD, neurosurgical interventions such as deep brain stimulation and stereotactic ablation have been applied as a “last resort” by selectively targeting one of a few key brain regions in the frontostriatal circuits. Aside from the remarkable therapeutic effects in treated patients, these neurostimulation procedures offer valuable insights into the pathophysiological role of individual regions in the OCD circuitry.
Dorsal anterior cingulotomy and anterior capsulotomy are the most commonly used stereotactic ablative procedures in the treatment of refractory OCD [71, 72]. Cingulotomy targets the dorsal ACC and cingulum bundle, disrupting anatomical connections between the dorsal ACC, ventral striatum, and limbic structures [73]. Volumetric reductions after anterior cingulotomy have been observed in the caudate, ventral temporal-fusiform, and posterior cingulate cortex [74, 75]. Meanwhile, anterior capsulotomy targets the anterior limb of the internal capsule (ALIC), which carries bidirectional fibers connecting the frontal cortex to deep gray matter including the thalamus and basal ganglia [76,77,78]. Thus, a study combining structural and diffusion MRI revealed that an ALIC lesion disrupts fiber integrity in the bilateral ALIC and anterior thalamic radiation, accompanied by a decrease in gray matter volume in the PFC, ACC, striatum, thalamus, and cerebellum [13]. Furthermore, bilateral capsulotomy has been reported to alter metabolic activity in the dorsal ACC, OFC, IFG, medial dorsal thalamus, caudate, and cerebellum [79, 80]. Importantly, functional connectivity between the ventral striatum and dorsal ACC has been selectively rectified by bilateral capsulotomy in association with symptom relief in patients with OCD [16].
As a reversible alternative to surgical lesions, deep brain stimulation has demonstrated remarkable success in mitigating refractory OCD symptoms [81]. Several targets have shown safety and efficacy, including ALIC, ventral ALIC/VS (VC/VS), NAc, and subthalamic nucleus (STN) [82]. PET studies have shown that stimulation of the ALIC reduces metabolic activity in the OFC [83, 84], subgenual ACC, and right dorsolateral PFC [85]. Using diffusion imaging, studies have confirmed that the connections between the stimulation site within the ALIC and the middle frontal gyrus are associated with clinical improvement [86, 87]. Because the ALIC is also widely used in lesion procedures, it has been suggested that deep brain stimulation and lesioning exert their effects in a similar manner [88, 89]. With regard to the VC/VS target, a recent study suggested that its effective site is primarily connected to the medial OFC, dorsomedial thalamus, amygdala, and habenula [90]. Meanwhile, for the NAc-DBS, a resting-state fMRI study reported that symptom relief was correlated with the normalization of excessive connectivity between the NAc and the lateral PFC [91]. Connections with the effective site in the STN-DBS, however, include the lateral OFC, dorsal ACC, and dorsolateral PFC [90]. Furthermore, DBS in the STN has been found to reduce glucose metabolism in the OFC, medial PFC, and ACC [92].
The effectiveness of non-invasive neuromodulation techniques such as transcranial magnetic stimulation (TMS) for OCD has also been examined. However, optimal targets and stimulation frequencies for OCD treatment are still under debate in the literature. Despite some inconsistency, several recent studies have shown promising results [93]. Specifically, two studies found that active stimulation over the dorsolateral PFC resulted in significant improvement of OCD symptoms compared to sham stimulation, although the sample size was relatively small (< 20) [94, 95]. In a prospective multicenter randomized double-blind placebo-controlled trial (n = 99), Carmi et al. [96] applied high-frequency deep TMS over the medial PFC and ACC in patients with OCD who failed to respond to treatment with medications and cognitive-behavioral therapy. The reduction in the Y-BOCS was significantly greater in the active group than that in the sham group and remained significant one month after treatment. In addition, the response rate in the active group was significantly higher than that in the sham group.
Despite different targets in multiple neuromodulation therapies, all the affected brain regions converge onto the fronto-striatal-thalamic circuits (Fig. 2B) [12, 97]. Several frequently modulated key regions are also involved in the emergence of OCD symptoms, such as the OFC, dorsal ACC, dorsolateral PFC, striatum, and thalamus [63, 65, 98]. We argue on the basis of this evidence that these are core regions that are crucial in neuromodulation-mediated recovery from severe, refractory OCD symptoms.
Although the concept of core regions in diagnostic classification has not yet been formalized, several pioneering studies have already adopted classification strategies that involve selecting core regions. For example, a large body of research suggests that the striatum plays a central role in schizophrenia, with dysfunction of the striatum tightly linked to schizophrenia symptoms [99, 100]. Based on this prior knowledge, Li et al. [101] developed an imaging biomarker for schizophrenia, which they refer to as “functional striatal abnormalities”, that integrates information from intra- and extra-striatal functional connectivity, as well as fALFF and ReHo within the striatum. In a large multi-site cohort (n = 1100), the “functional striatal abnormalities” score successfully distinguished patients with schizophrenia from HCs with an overall accuracy exceeding 80.4% (79.3% sensitivity and 81.5% specificity), which is comparable to the classification performance in other large cohort studies [102,103,104,105,106,107,108,109,110,111] (Fig. 2C). In another study, Chu et al. [112] compared the classification performance of four feature selection methods in Alzheimer’s disease (AD), including selecting regions of interest based on prior knowledge, univariate t-test, recursive feature elimination, and t-test constrained by regions of interest. Several important regions [113] implicated in AD were selected, such as the cingulate gyrus, hippocampus, and parahippocampal gyrus. Features from these key regions (the hippocampus and parahippocampal gyrus in particular) resulted in better performance compared to features selected based on data-driven approaches such as t-test and recursive feature elimination. Such findings suggest that core regions can meaningfully contribute to diagnostic labels and can be used to prevent the inclusion of features that capture redundant information. Further support for this concept comes from a study done by Sheng and colleagues [114], who proposed a novel classification method to identify stages of progression toward AD, i.e., HC, mild cognitive impairment, and AD. Their algorithm achieved 89.0% accuracy in three-group classification with features from 24 regions (360 regions in total). The authors further calculated the frequency of brain regions that were selected as features, and five regions appeared more frequently than others. Features from these 5 regions successfully classified three groups (5 regions, 80.0% versus 24 regions, 89.0%). These findings show that the entire brain may not be necessary for effective classification, suggesting that a subset of relevant regions is sufficient for diagnostic purposes. Although no studies applied a similar strategy in patients with OCD, these examples show that this core region-based strategy can easily be applied to other mental disorders.
Methods to Identify Core Regions in OCD
The evidence reviewed in previous sections highlights the potential of the core-region-based framework in diagnostic classification. Here we offer several methods for the selection of core regions from the whole brain to improve the diagnostic classification performance.
The roles of specific brain regions in the development and symptomology of OCD have been extensively studied and documented, resulting in rich literature. This information can be used as guidance to capture relevant features and maximize the efficiency of the classifiers. Teasing out irrelevant information is particularly important for high-dimensional neuroimaging data, which contain a large number of irrelevant and redundant features [24]. Zeng et al. [115] successfully applied this method by using patterns of functional connectivity to parcellate the perigenual ACC into two subregions (subgenual and pregenual) based on previous findings of dysfunction of the subgenual ACC in major depressive disorder (MDD) [116, 117] and its effectiveness as a target region for deep brain stimulation in refractory cases [118, 119]. They further used functional connectivity with these two subregions for the unsupervised classification of patients with MDD and healthy controls. Functional connectivity with the subgenual region achieved an individual‐level classification consistency of 92.5%, suggesting a core function of the subgenual ACC for the diagnostic classification of MDD. This approach has been successfully applied to other psychiatric disorders. For example, in post-traumatic stress disorder (PTSD), studies have reported abnormal resting-state functional connectivity both with the hippocampus and amygdala, and dysconnectivity with these two regions is correlated with the severity of PTSD [120]. Using functional connectivity with the amygdala as a feature, Fitzgerald et al. [121] demonstrated that the functional connectivity pattern with the amygdala is a reliable predictor of PTSD severity (n = 90, R = 0.46). Their later study [122] further showed that functional connectivity with the hippocampus can forecast the severity of PTSD symptoms in adult subjects 6 months after injury (n = 98, R = 0.30). Their findings support the view that the hippocampus and amygdala are core regions in PTSD diagnosis. Despite the usefulness of hypothesis-driven methods for screening core regions for diagnostic classification, this method has not yet been applied to feature selection in OCD.
A potential difficulty in identifying core regions in OCD is the contradictory findings among case-control studies in which imaging techniques are commonly used to examine the neural mechanisms underlying this disorder. These inconsistent findings may result from small sample sizes, medication, and duration of illness. These studies provide valuable but noisy information that is difficult to integrate and translate into clinical advances. One way to systematically combine results from several studies and obtain a conclusion with greater statistical power to draw out core regions in OCD is meta-analysis [123]. Moreover, meta-analysis has been successfully implemented as a method of feature selection. Specifically, Dukart et al. [124] combined datasets from structural MRI and [F18] fluorodeoxyglucose PET to automatically detect AD based on the results of meta-analyses [125]. Features extracted from meta-analyses resulted in an accuracy of 88.0% in one dataset (AD = 28, HC = 28), and 91.0% in an independent cohort (AD = 21, HC = 13). In another study, Sundermann et al. [126] used meta-analysis to screen resting state studies and extract key features of MDD. In subsequent research, the authors used all pairwise functional connectivity among 38 meta-analytically defined brain regions as features to classify 180 patients with MDD from 180 HCs [127]. However, the SVM models achieved diagnostic accuracies around the chance level in the training dataset. As meta-analysis methods pool information from numerous studies, this approach could increase the statistical power and therefore reduce type II errors. However, the bias in small datasets might undermine the advantages of the meta-analysis for feature reduction. Future studies in a large cohort are encouraged to validate the power of meta-analysis in feature selection.
OCD is a highly heterogeneous disease with high levels of comorbidity [10]. The high heterogeneity in patients with OCD adds noise to the neuroimaging features, making it difficult to extract the key features. To solve this problem, the recruitment of “pure patients” with OCD who do not meet the criteria for other psychiatric disorders has been proposed. However, stricter criteria make recruitment more difficult. Animal models of OCD (especially the nonhuman primate model) provide an alternative way to harmonize individual differences. A common and clear etiology could suppress noise from individual differences and improve efficiency to identify core regions for diagnostic classification. To achieve this, Zhan et al. [31] adopted a cross-species feature selection framework for screening key regions related to stereotypic behaviors. This was done using transgenic monkeys with methyl-CpG binding protein 2 overexpressed in the brain, which results in autism-like behaviors [128]. First, the group least absolute shrinkage and selection operator (LASSO) algorithm was applied in the transgenic monkey dataset to extract vital brain regions for distinguishing transgenic monkeys from typically developing monkeys. Specifically, nine core regions were extracted: the left central temporal cortex, right superior temporal cortex, right dorsolateral PFC, right primary somatosensory cortex, right primary motor cortex, left ACC, right centrolateral PFC, left superior parietal cortex, and right ventrolateral PFC. Next, the identified brain regions were considered as seed regions to construct classifiers for classification in human datasets. The monkey-derived classifier successfully distinguished the ASD cohort from HC with high accuracy, outperforming the human-derived classifiers (ABIDE-I cohort, 82.1% versus 61.3%; ABIDE-II cohort, 75.2% versus 60.4%). This pioneering study demonstrated the advantages of animal models for reducing clinical heterogeneity and providing valuable key features for human datasets.
Validation of Potential Core Regions in OCD
In animal models, a variety of techniques can be applied to up-regulate or down-regulate the activity in specific regions or circuits, such as optogenetics, chemogenetics, and deep brain stimulation [129, 130]. Animal models, therefore, provide a valuable platform in which to validate potential core regions in OCD. Hyperactivity in the OFC and striatum is tightly implicated in OCD, and successful treatments may normalize this hyperconnectivity [6]. Ahmari et al. [131] reported that repeated optogenetic excitation of the axon terminals of the OFC in the ventral striatum generated persistent grooming behavior, a well-known compulsive-like behavior in mice. Moreover, the elevated grooming evoked by chronic optogenetic modulation was reversed by fluoxetine. This study demonstrated the causal relationship between the OFC-striatal circuit and the pathophysiology of OCD. In mice, deletion of the Sapap3 gene induces excessive grooming [132]. Using optogenetic techniques, Burguière et al. [133] found that stimulation of the lateral OFC and its terminals in the striatum alleviated the elevated grooming response during a conditioning task. In a recent study, Ramírez-Armenta et al. [134] applied optogenetics to inhibit the activity of the dorsomedial striatum in Sapap3-knockout mice and found that specific suppression of the striatal indirect pathway neurons rescued the excessive grooming. These findings set good examples to validate the causal role of brain regions in the pathophysiology of OCD. In the future, validation of other proposed core regions will advance our understanding of the circuits of OCD and the clinical translation of neuroimaging-based diagnosis.
Perspectives
Transdiagnostic Perspective on OCD
Although obsession and compulsion are core OCD symptoms, there is substantial OCD comorbidity with anxiety, depression, and other symptoms [10]. Moreover, obsession and compulsion are broadly observed in other psychiatric disorders, including addiction, autism spectrum disorder, generalized anxiety disorder, and eating disorder. To overcome this problem, a Research Domain Criteria strategy has been proposed to shift the focus away from classical diagnostic categories and symptoms to dissecting the neural circuits underlying the maladaptive behavior [4, 135]. This strategy requires a transdiagnostic view of psychiatric disorders to map brain-behavior relationships. Several studies have suggested that compulsion is the main candidate for OCD and related disorders [136], and research has tried to dissect the neural mechanisms underlying compulsive behaviors across different diagnostic disorders. For instance, Montigny et al. [137] applied a higher-order two-factor model to extract the compulsivity construct in a multisite adolescent dataset (n = 1938), and brain gray matter volume in the bilateral OFC, right ventral striatum, and right dorsolateral PFC was significantly linked to the compulsivity. In a large multi-site dataset acquired from adolescent subjects (n = 11876, 9–10 years old, subclinical-clinical population), Pagliaccio et al. [138] examined the associations between obsessive-compulsive symptoms (OCS) and brain structural and functional data. They reported a negative correlation between OCS scores and fractional anisotropy of the superior corticostriatal tract, and higher OCS scores were associated with lower connectivity within the dorsal attention network and lower anticorrelation between the dorsal attention network and the default mode network. In a small cohort of children and adolescents (ASD = 24, OCD = 25), Akkermans et al. [139] reported that higher functional connectivity between the left NAc and right premotor/middle frontal gyrus is associated with more compulsivity measured by repetitive behaviors. These studies have implied the existence of a continuum of compulsivity. Further studies are encouraged to apply machine learning algorithms to identify key features related to compulsivity. Other key dimensions of OCD, like anxiety and obsession, are also important directions to dissect the heterogeneity in patients with OCD and related disorders.
From Classification to Prognostic Prediction
The search for neuroimaging biomarkers in the treatment of OCD is rapidly underway. Although several studies have tried to construct the relationship between baseline imaging data and treatment outcomes [140], machine learning algorithms have not been widely adopted [141,142,143]. In one of these studies, Reggente and colleagues [142] applied the LASSO regression algorithm to predict the treatment response to cognitive behavioral therapy based on baseline network connectivity patterns. They reported that the severity of OCD after treatment could be predicted by functional connectivity patterns within the default mode network and visual network, explaining up to 67% of the variance. Pagliaccio et al. [141] applied task-based fMRI data to predict the response to exposure therapy. The remission could be forecasted by brain activation within the cingulo-opercular and default mode network in the Simon spatial incompatibility task, specifically the anterior insula and anterior/posterior cingulate cortices. In future studies, it is promising to apply the features extracted from core regions in the diagnostic classification of OCD to the prediction of treatment outcomes.
Conclusions
Cross-sectional studies in OCD have advanced our understanding of its pathophysiology. However, inefficient diagnosis and poor treatment remain important issues in the field. With the rise of machine learning and neuroimaging, diagnostic classification using imaging biomarkers is rapidly developing. Although the sensitivity and specificity of classification are not optimized, this direction might shed light on the data-driven individualized diagnosis. The main problem in diagnostic classification is how to extract effective features to boost the performance of the algorithms. Taking together neuroimaging findings on the neural correlates of OCD, neuromodulation treatments, and practices in diagnostic classification, we propose a classification framework based on “core regions” of the brain, which are indispensable areas among the mass features for classification algorithms. We further introduce hypothesis-driven or data-driven methods to screen these core regions from the whole brain. Advanced circuit modulation techniques offer opportunities to interrogate the potential core regions proposed in patients. Meanwhile, data from other levels also provide different angles to understand the role of core regions in the context of the pathophysiology of OCD, such as the spatial transcriptome [144] and metabolome [145] in the brain. Nevertheless, heterogeneity and comorbidity in patients diagnosed based on symptoms still hinder precise diagnosis and treatment. A transition from the diagnostic category to a transdiagnostic view is urgently needed to push the improvement of the whole field. Besides, applying machine learning to prognosis is an important direction to achieve the goal of precise medicine [146].
References
Hyman SE. Can neuroscience be integrated into the DSM-V? Nat Rev Neurosci 2007, 8: 725–732.
Hyman SE. The diagnosis of mental disorders: The problem of reification. Annu Rev Clin Psychol 2010, 6: 155–179.
Sanislow CA, Pine DS, Quinn KJ, Kozak MJ, Garvey MA, Heinssen RK. Developing constructs for psychopathology research: Research domain criteria. J Abnorm Psychol 2010, 119: 631–639.
Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: The seven Pillars of RDoC. BMC Med 2013, 11: 126.
Milad MR, Rauch SL. Obsessive-compulsive disorder: Beyond segregated cortico-striatal pathways. Trends Cogn Sci 2012, 16: 43–51.
Robbins TW, Vaghi MM, Banca P. Obsessive-compulsive disorder: Puzzles and prospects. Neuron 2019, 102: 27–47.
Fawcett EJ, Power H, Fawcett JM. Women are at greater risk of OCD than men: A meta-analytic review of OCD prevalence worldwide. J Clin Psychiatry 2020, 81: 19r3085.
Elaine Battle D. Diagnostic and statistical manual of mental disorders (DSM). CoDAS 2013, 25: 191–192.
Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-brown obsessive compulsive scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989, 46: 1006–1011.
Gillan CM, Fineberg NA, Robbins TW. A trans-diagnostic perspective on obsessive-compulsive disorder. Psychol Med 2017, 47: 1528–1548.
Atmaca M. Review of structural neuroimaging in patients with refractory obsessivecompulsive disorder. Neurosci Bull 2011, 27: 215–220.
Chen X, Wang Z, Lv Q, Lv Q, van Wingen G, Fridgeirsson EA, et al. Common and differential connectivity profiles of deep brain stimulation and capsulotomy in refractory obsessive-compulsive disorder. Mol Psychiatry 2022, 27: 1020–1030.
Lv Q, Lv Q, Yin D, Zhang C, Sun B, Voon V, et al. Neuroanatomical substrates and predictors of response to capsulotomy in intractable obsessive-compulsive disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 2021, 6: 29–38.
Lv Q, Wang Z, Zhang C, Fan Q, Zhao Q, Zeljic K, et al. Divergent structural responses to pharmacological interventions in orbitofronto-striato-thalamic and premotor circuits in obsessive-compulsive disorder. EBioMedicine 2017, 22: 242–248.
Zhang C, Kim SG, Li J, Zhang Y, Lv Q, Zeljic K, et al. Anterior limb of the internal capsule tractography: Relationship with capsulotomy outcomes in obsessive-compulsive disorder. J Neurol Neurosurg Psychiatry 2021, 92: 637–644.
Yin D, Zhang C, Lv Q, Chen X, Zeljic K, Gong H, et al. Dissociable frontostriatal connectivity: Mechanism and predictor of the clinical efficacy of capsulotomy in obsessive-compulsive disorder. Biol Psychiatry 2018, 84: 926–936.
Mataix-Cols D, Wooderson S, Lawrence N, Brammer MJ, Speckens A, Phillips ML. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 2004, 61: 564–576.
van den Heuvel OA, Remijnse PL, Mataix-Cols D, Vrenken H, Groenewegen HJ, Uylings HBM, et al. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain 2009, 132: 853–868.
Ravindran A, Richter M, Jain T, Ravindran L, Rector N, Farb N. Functional connectivity in obsessive-compulsive disorder and its subtypes. Psychol Med 2020, 50: 1173–1181.
Wu X, Yu G, Zhang K, Feng J, Zhang J, Sahakian BJ, et al. Symptom-based profiling and multimodal neuroimaging of a large preteenage population identifies distinct obsessive-compulsive disorder-like subtypes with neurocognitive differences. Biol Psychiatry Cogn Neurosci Neuroimaging 2022, 7: 1078–1089.
Han S, Xu Y, Guo HR, Fang K, Wei Y, Liu L, et al. Two distinct subtypes of obsessive compulsive disorder revealed by a framework integrating multimodal neuroimaging information. Hum Brain Mapp 2022, 43: 4254–4265.
Rashid B, Calhoun V. Towards a brain-based predictome of mental illness. Hum Brain Mapp 2020, 41: 3468–3535.
Bruin W, Denys D, van Wingen G. Diagnostic neuroimaging markers of obsessive-compulsive disorder: Initial evidence from structural and functional MRI studies. Prog Neuro Psychopharmacol Biol Psychiatry 2019, 91: 49–59.
Mwangi B, Tian TS, Soares JC. A review of feature reduction techniques in neuroimaging. Neuroinform 2014, 12: 229–244.
Yang Z, Fang F, Weng X. Recent developments in multivariate pattern analysis for functional MRI. Neurosci Bull 2012, 28: 399–408.
Orrù G, Pettersson-Yeo W, Marquand AF, Sartori G, Mechelli A. Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: A critical review. Neurosci Biobehav Rev 2012, 36: 1140–1152.
Woo CW, Chang LJ, Lindquist MA, Wager TD. Building better biomarkers: Brain models in translational neuroimaging. Nat Neurosci 2017, 20: 365–377.
Pu J, Wang J, Yu W, Shen Z, Lv Q, Zeljic K, et al. Discriminative structured feature engineering for macroscale brain connectomes. IEEE Trans Med Imaging 2015, 34: 2333–2342.
Goodman WK, Storch EA, Sheth SA. Harmonizing the neurobiology and treatment of obsessive-compulsive disorder. Am J Psychiatry 2021, 178: 17–29.
First MB, Drevets WC, Carter C, Dickstein DP, Kasoff L, Kim KL, et al. Clinical applications of neuroimaging in psychiatric disorders. Am J Psychiatry 2018, 175: 915–916.
Zhan Y, Wei J, Liang J, Xu X, He R, Robbins TW, et al. Diagnostic classification for human autism and obsessive-compulsive disorder based on machine learning from a primate genetic model. Am J Psychiatry 2021, 178: 65–76.
Kalmady SV, Paul AK, Narayanaswamy JC, Agrawal R, Shivakumar V, Greenshaw AJ, et al. Prediction of obsessive-compulsive disorder: Importance of neurobiology-aided feature design and cross-diagnosis transfer learning. Biol Psychiatry Cogn Neurosci Neuroimaging 2022, 7: 735–746.
Yang X, Hu X, Tang W, Li B, Yang Y, Gong Q, et al. Multivariate classification of drug-naive obsessive-compulsive disorder patients and healthy controls by applying an SVM to resting-state functional MRI data. BMC Psychiatry 2019, 19: 210.
Xing X, Jin L, Li Q, Yang Q, Han H, Xu C, et al. Modeling essential connections in obsessive-compulsive disorder patients using functional MRI. Brain Behav 2020, 10: e01499.
Liu W, Hua M, Qin J, Tang Q, Han Y, Tian H, et al. Disrupted pathways from frontal-parietal cortex to basal Ganglia and cerebellum in patients with unmedicated obsessive compulsive disorder as observed by whole-brain resting-state effective connectivity analysis - a small sample pilot study. Brain Imaging Behav 2021, 15: 1344–1354.
Hu X, Liu Q, Li B, Tang W, Sun H, Li F, et al. Multivariate pattern analysis of obsessive-compulsive disorder using structural neuroanatomy. Eur Neuropsychopharmacol 2016, 26: 246–254.
Hu X, Zhang L, Bu X, Li H, Li B, Tang W, et al. Localized connectivity in obsessive-compulsive disorder: An investigation combining univariate and multivariate pattern analyses. Front Behav Neurosci 2019, 13: 122.
Luo Q, Liu W, Jin L, Chang C, Peng Z. Classification of obsessive-compulsive disorder using distance correlation on resting-state functional MRI images. Front Neuroinform 2021, 15: 676491.
Jia C, Ou Y, Chen Y, Li P, Lv D, Yang R, et al. Decreased resting-state interhemispheric functional connectivity in medication-free obsessive-compulsive disorder. Front Psychiatry 2020, 11: 559729.
Zhou C, Cheng Y, Ping L, Xu J, Shen Z, Jiang L, et al. Support vector machine classification of obsessive-compulsive disorder based on whole-brain volumetry and diffusion tensor imaging. Front Psychiatry 2018, 9: 524.
Gruner P, Vo A, Argyelan M, Ikuta T, Degnan AJ, John M, et al. Independent component analysis of resting state activity in pediatric obsessive-compulsive disorder. Hum Brain Mapp 2014, 35: 5306–5315.
Li F, Huang X, Tang W, Yang Y, Li B, Kemp GJ, et al. Multivariate pattern analysis of DTI reveals differential white matter in individuals with obsessive-compulsive disorder. Hum Brain Mapp 2014, 35: 2643–2651.
Liu J, Bu X, Hu X, Li H, Cao L, Gao Y, et al. Temporal variability of regional intrinsic neural activity in drug-naïve patients with obsessive-compulsive disorder. Hum Brain Mapp 2021, 42: 3792–3803.
Trambaiolli LR, Biazoli CE Jr, Balardin JB, Hoexter MQ, Sato JR. The relevance of feature selection methods to the classification of obsessive-compulsive disorder based on volumetric measures. J Affect Disord 2017, 222: 49–56.
Parrado-Hernández E, Gómez-Verdejo V, Martínez-Ramón M, Shawe-Taylor J, Alonso P, Pujol J, et al. Discovering brain regions relevant to obsessive-compulsive disorder identification through bagging and transduction. Med Image Anal 2014, 18: 435–448.
Yang P, Zhao C, Yang Q, Wei Z, Xiao X, Shen L, et al. Diagnosis of obsessive-compulsive disorder via spatial similarity-aware learning and fused deep polynomial network. Med Image Anal 2022, 75: 102244.
Soriano-Mas C, Pujol J, Alonso P, Cardoner N, Menchón JM, Harrison BJ, et al. Identifying patients with obsessive-compulsive disorder using whole-brain anatomy. NeuroImage 2007, 35: 1028–1037.
Weygandt M, Blecker CR, Schäfer A, Hackmack K, Haynes JD, Vaitl D, et al. fMRI pattern recognition in obsessive-compulsive disorder. NeuroImage 2012, 60: 1186–1193.
Sen B, Bernstein GA, Mueller BA, Cullen KR, Parhi KK. Sub-graph entropy based network approaches for classifying adolescent obsessive-compulsive disorder from resting-state functional MRI. Neuroimage Clin 2020, 26: 102208.
Yun JY, Jang JH, Kim SN, Jung WH, Kwon JS. Neural correlates of response to pharmacotherapy in obsessive-compulsive disorder: Individualized cortical morphology-based structural covariance. Prog Neuro Psychopharmacol Biol Psychiatry 2015, 63: 126–133.
Liu W, Qin J, Tang Q, Han Y, Fang T, Zhang Z, et al. Disrupted pathways from the frontal-parietal cortices to basal nuclei and the cerebellum are a feature of the obsessive-compulsive disorder spectrum and can be used to aid in early differential diagnosis. Psychiatry Res 2020, 293: 113436.
Takagi Y, Sakai Y, Lisi G, Yahata N, Abe Y, Nishida S, et al. A neural marker of obsessive-compulsive disorder from whole-brain functional connectivity. Sci Rep 2017, 7: 7538.
Bu X, Hu X, Zhang L, Li B, Zhou M, Lu L, et al. Investigating the predictive value of different resting-state functional MRI parameters in obsessive-compulsive disorder. Transl Psychiatry 2019, 9: 17.
Bruin WB, Taylor L, Thomas RM, Shock JP, Zhutovsky P, Abe Y, et al. Structural neuroimaging biomarkers for obsessive-compulsive disorder in the ENIGMA-OCD consortium: Medication matters. Transl Psychiatry 2020, 10: 342.
Biswal B, Yetkin FZ, Haughton VM, Hyde JS. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 1995, 34: 537–541.
Fornito A, Bullmore ET. What can spontaneous fluctuations of the blood oxygenation-level-dependent signal tell us about psychiatric disorders? Curr Opin Psychiatry 2010, 23: 239–249.
Greicius M. Resting-state functional connectivity in neuropsychiatric disorders. Curr Opin Neurol 2008, 21: 424–430.
Kalmady SV, Greiner R, Agrawal R, Shivakumar V, Narayanaswamy JC, Brown MRG, et al. Towards artificial intelligence in mental health by improving schizophrenia prediction with multiple brain parcellation ensemble-learning. NPJ Schizophr 2019, 5: 2.
Boedhoe PSW, Schmaal L, Abe Y, Ameis SH, Arnold PD, Batistuzzo MC, et al. Distinct subcortical volume alterations in pediatric and adult OCD: A worldwide meta- and mega-analysis. Am J Psychiatry 2017, 174: 60–69.
Boedhoe PSW, Schmaal L, Abe Y, Alonso P, Ameis SH, Anticevic A, et al. Cortical abnormalities associated with pediatric and adult obsessive-compulsive disorder: Findings from the ENIGMA obsessive-compulsive disorder working group. Am J Psychiatry 2018, 175: 453–462.
Baxter LR Jr, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 1987, 44: 211–218.
Baxter LR Jr, Schwartz JM, Mazziotta JC, Phelps ME, Pahl JJ, Guze BH, et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry 1988, 145: 1560–1563.
Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl 1998: 26–37.
Swedo SE, Schapiro MB, Grady CL, Cheslow DL, Leonard HL, Kumar A, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989, 46: 518–523.
Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited. Neurosci Biobehav Rev. 2008, 32: 525–549.
Whitwell JL. Voxel-based morphometry: An automated technique for assessing structural changes in the brain. J Neurosci 2009, 29: 9661–9664.
Wright IC, McGuire PK, Poline JB, Travere JM, Murray RM, Frith CD, et al. A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. NeuroImage 1995, 2: 244–252.
de Wit SJ, Alonso P, Schweren L, Mataix-Cols D, Lochner C, Menchón JM, et al. Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder. Am J Psychiatry 2014, 171: 340–349.
Shephard E, Stern ER, van den Heuvel OA, Costa DLC, Batistuzzo MC, Godoy PBG, et al. Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder. Mol Psychiatry 2021, 26: 4583–4604.
van den Heuvel OA, van Wingen G, Soriano-Mas C, Alonso P, Chamberlain SR, Nakamae T, et al. Brain circuitry of compulsivity. Eur Neuropsychopharmacol 2016, 26: 810–827.
Greenberg BD, Rauch SL, Haber SN. Invasive circuitry-based neurotherapeutics: Stereotactic ablation and deep brain stimulation for OCD. Neuropsychopharmacology 2010, 35: 317–336.
Brown LT, Mikell CB, Youngerman BE, Zhang Y, McKhann GM 2nd, Sheth SA. Dorsal anterior cingulotomy and anterior capsulotomy for severe, refractory obsessive-compulsive disorder: A systematic review of observational studies. J Neurosurg 2016, 124: 77–89.
Bubb EJ, Metzler-Baddeley C, Aggleton JP. The cingulum bundle: Anatomy, function, and dysfunction. Neurosci Biobehav Rev 2018, 92: 104–127.
Rauch SL, Kim H, Makris N, Cosgrove GR, Cassem EH, Savage CR, et al. Volume reduction in the caudate nucleus following stereotactic placement of lesions in the anterior cingulate cortex in humans: A morphometric magnetic resonance imaging study. J Neurosurg 2000, 93: 1019–1025.
Rauch SL, Makris N, Cosgrove GR, Kim H, Cassem EH, Price BH, et al. A magnetic resonance imaging study of regional cortical volumes following stereotactic anterior cingulotomy. CNS Spectr 2001, 6: 214–222.
Cummings JL. Anatomic and behavioral aspects of frontal-subcortical circuits. Ann N Y Acad Sci 1995, 769: 1–13.
Nanda P, Banks GP, Pathak YJ, Sheth SA. Connectivity-based parcellation of the anterior limb of the internal capsule. Hum Brain Mapp 2017, 38: 6107–6117.
Safadi Z, Grisot G, Jbabdi S, Behrens TE, Heilbronner SR, McLaughlin NCR, et al. Functional segmentation of the anterior limb of the internal capsule: Linking white matter abnormalities to specific connections. J Neurosci 2018, 38: 2106–2117.
Zuo C, Ma Y, Sun B, Peng S, Zhang H, Eidelberg D, et al. Metabolic imaging of bilateral anterior capsulotomy in refractory obsessive compulsive disorder: An FDG PET study. J Cereb Blood Flow Metab 2013, 33: 880–887.
Suetens K, Nuttin B, Gabriëls L, Van Laere K. Differences in metabolic network modulation between capsulotomy and deep-brain stimulation for refractory obsessive-compulsive disorder. J Nucl Med 2014, 55: 951–959.
Pepper J, Hariz M, Zrinzo L. Deep brain stimulation versus anterior capsulotomy for obsessive-compulsive disorder: A review of the literature. J Neurosurg 2015, 122: 1028–1037.
Wu H, Hariz M, Visser-Vandewalle V, Zrinzo L, Coenen VA, Sheth SA, et al. Deep brain stimulation for refractory obsessive-compulsive disorder (OCD): Emerging or established therapy? Mol Psychiatry 2021, 26: 60–65.
Nuttin BJ, Gabriëls LA, Cosyns PR, Meyerson BA, Andréewitch S, Sunaert SG, et al. Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder. Neurosurgery 2003, 52: 1263–1272;discussion 1272–1274.
Abelson JL, Curtis GC, Sagher O, Albucher RC, Harrigan M, Taylor SF, et al. Deep brain stimulation for refractory obsessive-compulsive disorder. Biol Psychiatry 2005, 57: 510–516.
Van Laere K, Nuttin B, Gabriels L, Dupont P, Rasmussen S, Greenberg BD, et al. Metabolic imaging of anterior capsular stimulation in refractory obsessive-compulsive disorder: A key role for the subgenual anterior cingulate and ventral striatum. J Nucl Med 2006, 47: 740–747.
Hartmann CJ, Lujan JL, Chaturvedi A, Goodman WK, Okun MS, McIntyre CC, et al. Tractography activation patterns in dorsolateral prefrontal cortex suggest better clinical responses in OCD DBS. Front Neurosci 2015, 9: 519.
Baldermann JC, Melzer C, Zapf A, Kohl S, Timmermann L, Tittgemeyer M, et al. Connectivity profile predictive of effective deep brain stimulation in obsessive-compulsive disorder. Biol Psychiatry 2019, 85: 735–743.
Lozano AM, Lipsman N, Bergman H, Brown P, Chabardes S, Chang JW, et al. Deep brain stimulation: Current challenges and future directions. Nat Rev Neurol 2019, 15: 148–160.
Chen X, Zhang C, Li Y, Huang P, Lv Q, Yu W, et al. Functional connectivity-based modelling simulates subject-specific network spreading effects of focal brain stimulation. Neurosci Bull 2018, 34: 921–938.
Tyagi H, Apergis-Schoute AM, Akram H, Foltynie T, Limousin P, Drummond LM, et al. A randomized trial directly comparing ventral capsule and anteromedial subthalamic nucleus stimulation in obsessive-compulsive disorder: Clinical and imaging evidence for dissociable effects. Biol Psychiatry 2019, 85: 726–734.
Figee M, Luigjes J, Smolders R, Valencia-Alfonso CE, van Wingen G, de Kwaasteniet B, et al. Deep brain stimulation restores frontostriatal network activity in obsessive-compulsive disorder. Nat Neurosci 2013, 16: 386–387.
Le Jeune F, Vérin M, N’Diaye K, Drapier D, Leray E, Tezenas Du Montcel S, et al. Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: A positron emission tomography study. Biol Psychiatry 2010, 68: 1016–1022.
Liang K, Li H, Bu X, Li X, Cao L, Liu J, et al. Efficacy and tolerability of repetitive transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder in adults: A systematic review and network meta-analysis. Transl Psychiatry 2021, 11: 332.
Seo HJ, Jung YE, Lim HK, Um YH, Lee CU, Chae JH. Adjunctive low-frequency repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex in patients with treatment-resistant obsessive-compulsive disorder: A randomized controlled trial. Clin Psychopharmacol Neurosci 2016, 14: 153–160.
Haghighi M, Shayganfard M, Jahangard L, Ahmadpanah M, Bajoghli H, Pirdehghan A, et al. Repetitive Transcranial Magnetic Stimulation (rTMS) improves symptoms and reduces clinical illness in patients suffering from OCD—Results from a single-blind, randomized clinical trial with sham cross-over condition. J Psychiatr Res 2015, 68: 238–244.
Carmi L, Tendler A, Bystritsky A, Hollander E, Blumberger DM, Daskalakis J, et al. Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: A prospective multicenter randomized double-blind placebo-controlled trial. Focus (Am Psychiatr Publ) 2022, 20: 152–159.
Fox MD, Buckner RL, Liu H, Chakravarty MM, Lozano AM, Pascual-Leone A. Resting-state networks link invasive and noninvasive brain stimulation across diverse psychiatric and neurological diseases. Proc Natl Acad Sci U S A 2014, 111: E4367–E4375.
Anticevic A, Hu S, Zhang S, Savic A, Billingslea E, Wasylink S, et al. Global resting-state functional magnetic resonance imaging analysis identifies frontal cortex, striatal, and cerebellar dysconnectivity in obsessive-compulsive disorder. Biol Psychiatry 2014, 75: 595–605.
Simpson EH, Kellendonk C, Kandel E. A possible role for the Striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron 2010, 65: 585–596.
McCutcheon RA, Abi-Dargham A, Howes OD. Schizophrenia, dopamine and the Striatum: From biology to symptoms. Trends Neurosci 2019, 42: 205–220.
Li A, Zalesky A, Yue W, Howes O, Yan H, Liu Y, et al. A neuroimaging biomarker for striatal dysfunction in schizophrenia. Nat Med 2020, 26: 558–565.
Rozycki M, Satterthwaite TD, Koutsouleris N, Erus G, Doshi J, Wolf DH, et al. Multisite machine learning analysis provides a robust structural imaging signature of schizophrenia detectable across diverse patient populations and within individuals. Schizophr Bull 2018, 44: 1035–1044.
Hu K, Wang M, Liu Y, Yan H, Song M, Chen J, et al. Multisite schizophrenia classification by integrating structural magnetic resonance imaging data with polygenic risk score. Neuroimage Clin 2021, 32: 102860.
Vieira S, Gong QY, Pinaya WHL, Scarpazza C, Tognin S, Crespo-Facorro B, et al. Using machine learning and structural neuroimaging to detect first episode psychosis: Reconsidering the evidence. Schizophr Bull 2020, 46: 17–26.
Cheng W, Palaniyappan L, Li M, Kendrick KM, Zhang J, Luo Q, et al. Addendum: Voxel-based, brain-wide association study of aberrant functional connectivity in schizophrenia implicates thalamocortical circuitry. NPJ Schizophr 2018, 4: 19.
Zeng LL, Wang H, Hu P, Yang B, Pu W, Shen H, et al. Multi-site diagnostic classification of schizophrenia using discriminant deep learning with functional connectivity MRI. EBioMedicine 2018, 30: 74–85.
Zhao M, Yan W, Luo N, Zhi D, Fu Z, Du Y, et al. An attention-based hybrid deep learning framework integrating brain connectivity and activity of resting-state functional MRI data. Med Image Anal 2022, 78: 102413.
Chen J, Patil KR, Weis S, Sim K, Nickl-Jockschat T, Zhou J, et al. Neurobiological divergence of the positive and negative schizophrenia subtypes identified on a new factor structure of psychopathology using non-negative factorization: An international machine learning study. Biol Psychiatry 2020, 87: 282–293.
Xie Y, Ding H, Du X, Chai C, Wei X, Sun J, et al. Morphometric integrated classification index: A multisite model-based, interpretable, shareable and evolvable biomarker for schizophrenia. Schizophr Bull 2022, 48: 1217–1227.
Yan W, Calhoun V, Song M, Cui Y, Yan H, Liu S, et al. Discriminating schizophrenia using recurrent neural network applied on time courses of multi-site FMRI data. EBioMedicine 2019, 47: 543–552.
Lei D, Qin K, Pinaya WHL, Young J, Van Amelsvoort T, Marcelis M, et al. Graph convolutional networks reveal network-level functional dysconnectivity in schizophrenia. Schizophr Bull 2022, 48: 881–892.
Chu C, Hsu AL, Chou KH, Bandettini P, Lin C. Alzheimer’s Disease Neuroimaging Initiative. Does feature selection improve classification accuracy? Impact of sample size and feature selection on classification using anatomical magnetic resonance images. Neuroimage 2012, 60: 59–70.
Pennanen C, Testa C, Laakso MP, Hallikainen M, Helkala EL, Hänninen T, et al. A voxel based morphometry study on mild cognitive impairment. J Neurol Neurosurg Psychiatry 2005, 76: 11–14.
Sheng J, Shao M, Zhang Q, Zhou R, Wang L, Xin Y. Alzheimer’s disease, mild cognitive impairment, and normal aging distinguished by multi-modal parcellation and machine learning. Sci Rep 2020, 10: 5475.
Zeng LL, Shen H, Liu L, Hu D. Unsupervised classification of major depression using functional connectivity MRI. Hum Brain Mapp 2014, 35: 1630–1641.
Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, et al. Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness. Am J Psychiatry 1999, 156: 675–682.
Greicius MD, Flores BH, Menon V, Glover GH, Solvason HB, Kenna H, et al. Resting-state functional connectivity in major depression: Abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry 2007, 62: 429–437.
Underwood E. Short-circuiting depression. Science 2013, 342: 548–551.
Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45: 651–660.
Fitzgerald JM, DiGangi JA, Phan KL. Functional neuroanatomy of emotion and its regulation in PTSD. Harv Rev Psychiatry 2018, 26: 116–128.
Fitzgerald JM, Belleau EL, Miskovich TA, Pedersen WS, Larson CL. Multi-voxel pattern analysis of amygdala functional connectivity at rest predicts variability in posttraumatic stress severity. Brain Behav 2020, 10: e01707.
Fitzgerald JM, Webb EK, Weis CN, Huggins AA, Bennett KP, Miskovich TA, et al. Hippocampal resting-state functional connectivity forecasts individual posttraumatic stress disorder symptoms: A data-driven approach. Biol Psychiatry Cogn Neurosci Neuroimaging 2022, 7: 139–149.
Salimi-Khorshidi G, Smith SM, Keltner JR, Wager TD, Nichols TE. Meta-analysis of neuroimaging data: A comparison of image-based and coordinate-based pooling of studies. NeuroImage 2009, 45: 810–823.
Dukart J, Mueller K, Barthel H, Villringer A, Sabri O, Schroeter ML, et al. Meta-analysis based SVM classification enables accurate detection of Alzheimer’s disease across different clinical centers using FDG-PET and MRI. Psychiatry Res 2013, 212: 230–236.
Schroeter ML, Stein T, Maslowski N, Neumann J. Neural correlates of Alzheimer’s disease and mild cognitive impairment: A systematic and quantitative meta-analysis involving 1351 patients. Neuroimage 2009, 47: 1196–1206.
Sundermann B, Olde Lütke Beverborg M, Pfleiderer B. Toward literature-based feature selection for diagnostic classification: A meta-analysis of resting-state fMRI in depression. Front Hum Neurosci 2014, 8: 692.
Sundermann B, Feder S, Wersching H, Teuber A, Schwindt W, Kugel H, et al. Diagnostic classification of unipolar depression based on resting-state functional connectivity MRI: Effects of generalization to a diverse sample. J Neural Transm 2017, 124: 589–605.
Liu Z, Li X, Zhang JT, Cai YJ, Cheng TL, Cheng C, et al. Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2. Nature 2016, 530: 98–102.
Fenno L, Yizhar O, Deisseroth K. The development and application of optogenetics. Annu Rev Neurosci 2011, 34: 389–412.
Sternson SM, Roth BL. Chemogenetic tools to interrogate brain functions. Annu Rev Neurosci 2014, 37: 387–407.
Ahmari SE, Spellman T, Douglass NL, Kheirbek MA, Simpson HB, Deisseroth K, et al. Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science 2013, 340: 1234–1239.
Welch JM, Lu J, Rodriguiz RM, Trotta NC, Peca J, Ding JD, et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 2007, 448: 894–900.
Burguière E, Monteiro P, Feng G, Graybiel AM. Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science 2013, 340: 1243–1246.
Ramírez-Armenta KI, Alatriste-León H, Verma-Rodríguez AK, Llanos-Moreno A, Ramírez-Jarquín JO, Tecuapetla F. Optogenetic inhibition of indirect pathway neurons in the dorsomedial striatum reduces excessive grooming in Sapap3-knockout mice. Neuropsychopharmacology 2022, 47: 477–487.
Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders. Am J Psychiatry 2010, 167: 748–751.
Robbins TW, Gillan CM, Smith DG, de Wit S, Ersche KD. Neurocognitive endophenotypes of impulsivity and compulsivity: Towards dimensional psychiatry. Trends Cogn Sci 2012, 16: 81–91.
Montigny C, Castellanos-Ryan N, Whelan R, Banaschewski T, Barker GJ, Büchel C, et al. A phenotypic structure and neural correlates of compulsive behaviors in adolescents. PLoS One 2013, 8: e80151.
Pagliaccio D, Durham K, Fitzgerald KD, Marsh R. Obsessive-compulsive symptoms among children in the adolescent brain and cognitive development study: Clinical, cognitive, and brain connectivity correlates. Biol Psychiatry Cogn Neurosci Neuroimaging 2021, 6: 399–409.
Akkermans SEA, Rheinheimer N, Bruchhage MMK, Durston S, Brandeis D, Banaschewski T, et al. Frontostriatal functional connectivity correlates with repetitive behaviour across autism spectrum disorder and obsessive-compulsive disorder. Psychol Med 2019, 49: 2247–2255.
Fullana MA, Simpson HB. The potential use of neuroimaging biomarkers in the treatment of obsessive-compulsive disorder. Curr Treat Options Psych 2016, 3: 246–252.
Pagliaccio D, Middleton R, Hezel D, Steinman S, Snorrason I, Gershkovich M, et al. Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder. Proc Natl Acad Sci U S A 2019, 116: 20346–20353.
Reggente N, Moody TD, Morfini F, Sheen C, Rissman J, O’Neill J, et al. Multivariate resting-state functional connectivity predicts response to cognitive behavioral therapy in obsessive-compulsive disorder. Proc Natl Acad Sci U S A 2018, 115: 2222–2227.
Pagliaccio D, Cha J, He X, Cyr M, Yanes-Lukin P, Goldberg P, et al. Structural neural markers of response to cognitive behavioral therapy in pediatric obsessive-compulsive disorder. J Child Psychol Psychiatry 2020, 61: 1299–1308.
Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 2012, 489: 391–399.
Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, et al. HMDB: The human metabolome database. Nucleic Acids Res 2007, 35: D521–D526.
Bzdok D, Meyer-Lindenberg A. Machine learning for precision psychiatry: Opportunities and challenges. Biol Psychiatry Cogn Neurosci Neuroimaging 2018, 3: 223–230.
Acknowledgements
This review was supported by the Key-Area Research and Development Program of Guangdong Province (2019B030335001), the National Natural Science Foundation of China (82151303), the National Key R&D Program of China (2021ZD0204002), and Peking-Tsinghua Centre for Life Sciences. Qian Lv was supported by a Postdoctoral Fellowship of the Peking-Tsinghua Center for Life Sciences.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lv, Q., Zeljic, K., Zhao, S. et al. Dissecting Psychiatric Heterogeneity and Comorbidity with Core Region-Based Machine Learning. Neurosci. Bull. 39, 1309–1326 (2023). https://doi.org/10.1007/s12264-023-01057-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12264-023-01057-2